Walleye Capital’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-22,300
Closed -$2.9M 5048
2025
Q4
$2.9M Buy
22,300
+17,400
+355% +$2.39M 0.01% 1563
2025
Q3
$528K Buy
4,900
+1,000
+26% +$109K ﹤0.01% 2561
2025
Q2
$360K Buy
3,900
+1,200
+44% +$94.2K ﹤0.01% 2922
2025
Q1
$239K Sell
2,700
-1,100
-29% -$95.4K ﹤0.01% 3129
2024
Q4
$292K Buy
+3,800
New +$265K ﹤0.01% 3446

Other funds holding WGS

Walleye Capital's WGS Position: Q2 2026 in Review

Walleye Capital opened a new position in GeneDx Holdings (WGS) in Q2 2026: 67,900 shares worth $4.66M. The stake represents 0.02% of the portfolio and ranks #867 among its holdings. This is a return to the name: Walleye Capital previously reported a position in WGS as recently as Q4 2025.

Walleye Capital first reported a position in WGS in Q4 2020 and has held it in 5 quarters since. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Walleye Capital held 67,900 shares of GeneDx Holdings worth $4.66M as of Q2 2026.
  • GeneDx Holdings was a new Walleye Capital position in Q2 2026.
  • GeneDx Holdings made up 0.02% of Walleye Capital's portfolio in Q2 2026, its #867 holding.
  • Walleye Capital first reported a position in GeneDx Holdings in Q4 2020 and has held it in 5 quarters since.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.